In January, the U.S. FDA said a preliminary review showed no evidence of such a link, though the agency said it could not rule out that ‘a small risk may exist.’
Meanwhile, the College of Pharmacists of British Columbia has launched its own survey, with questions adapted from the surveys in Ontario and Saskatchewan.